Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19: a longitudinal cohort study-Reference-Cited by-同舟云学术

Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19: a longitudinal cohort study

Published:2024-01 Issue:1 Volume:5 Page:e24-e33
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Guo Li,Zhang Qiao,Gu Xiaoying,Ren Lili,Huang Tingxuan,Li Yanan,Zhang Hui,Liu Ying,Zhong Jingchuan,Wang Xinming,Chen Lan,Zhang Yin,Li Danyang,Fang Meiyu,Xu Liuhui,Li Haibo,Wang Zai,Li Hui,Bai Tao,Liu Wen,Peng Yanchun,Dong Tao,Cao Bin,Wang Jianwei

Funder

UKRI Medical Research Council

National Natural Science Foundation of China

Science Fund for Creative Research Groups

Beijing Natural Science Foundation

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Reference26 articles.

1. The immunology and immunopathology of COVID-19;Merad;Science,2022

2. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study;Guo;Lancet Microbe,2022

3. The T cell immune response against SARS-CoV-2;Moss;Nat Immunol,2022

4. Understanding T cell responses to COVID-19 is essential for informing public health strategies;Vardhana;Sci Immunol,2022

5. Antibody-mediated neutralization of SARS-CoV-2;Gruell;Immunity,2022

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine;Vaccines;2024-08-26

2. SARS-CoV-2 Vaccination Responses in Anti-CD20-Treated Progressive Multiple Sclerosis Patients Show Immunosenescence in Antigen-Specific B and T Cells;Vaccines;2024-08-17

3. Immune responses in COVID-19 patients: Insights into cytokine storms and adaptive immunity kinetics;Heliyon;2024-07

4. SARS-CoV-2 Humoral and Cellular Immune Responses in People Living with HIV;Vaccines;2024-06-16

5. SARS-CoV-2-identical protein regions found in mammalian coronaviruses have immunogenic potential and can imply cross-protection;ImmunoInformatics;2024-06